Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Infections and Infectious Diseases | Family Medicine
Disease Category: Gynecological Infections
Location: United States, GA
GOG 0250: A RANDOMIZED PHASE III EVALUATION OF DOCETAXEL AND GEMCITABINE PLUS G-CSF WITH BEVACIZUMAB, VERSUS DOCETAXEL AND GEMCITABINE PLUS G-CSF WITH PLACEBO IN THE TREATMENT OF RECURRENT OR ADVANCED LEIOMYOSARCOMA OF THE UTERUS. NCI SUPPLIED AGENT: BEVACIZUMAB.
For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01012297?term=gog+0250&rank=1
Memorial University Medical Center
4700 Waters Avenue
Hoskins Center - 2nd Floor
Savannah, GA 31404
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these